What's new in pharmaDecember 12, 2025Check out STAT+Sponsored By By Ed SilvermanPharmalot Columnist, Senior Writer Photo illustration: Alex Hogan/STAT; Screen capture via YouTube STAT+ | FDA staff fear Tracy Beth Høeg will bring bias and instability to embattled drug center Tracy Beth Høeg, fifth CDER director in a year, faces questions about impartiality. HHS expresses confidence, dismisses 'anonymous detractors.' By Lizzy Lawrence STAT+ | As superbug fears grow, sales of antibiotics used in food-producing livestock rose dramatically last year The report arrives as antibiotic resistance generates anxiety amid inconsistent efforts to provide incentives for antibiotic development By Ed Silverman FDA approves first new kind of drug to target gonorrhea in decades Sexually transmitted infection has developed resistance to nearly every antibiotic used against it. Nuzolvence is the second new treatment approved this week. By Helen Branswell Joe Raedle/Getty Images Opinion: I'm a CVS pharmacist. My retail pharmacy colleagues and I face a crisis What happens when pharmacists are expected to perform at the same level while the workplace condition deteriorates? By Chris Eggeman How hepatitis B vaccine changes could add confusion for families, limit protection against other diseases Vaccines are often combined to reduce the total number of injections. Separate hep B shots could disrupt vaccine supply, limit access for years. By Helen Branswell More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Pharmalot? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2025, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments